Skip to main content

Ginkgo Bioworks is expanding again in Boston’s Seaport

The biotech company company recently went public in a SPAC deal valued at $17.5 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.